Akili Interactive announces board nominees ahead of SPAC and more digital health hires
Akili Interactive, maker of a video-game-like digital therapeutic for treating pediatric ADHD, announced nominees for its board of directors once the company goes public. The nominees for the public board include William BJ Jones, a chief commercial officer at Biohaven Pharmaceuticals; Christine Lemke, co-CEO of Evidation Health; Ken Ehlert, former chief scientific officer at UnitedHealth